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ABSTRACT
Introduction: In 2013, the World Health Organization (WHO) reported that 1.9 million 
pregnant women were infected with syphilis worldwide, of which 66.5% had adverse fetal 
effects in cases of untreated syphilis. Congenital syphilis contributes significantly to infant 
mortality, accounting for 305,000 perinatal deaths worldwide annually. Aim: To estimate 
the prevalence of syphilis in parturients, the incidence of congenital syphilis and the vertical 
transmission rate. Material and methods: a cross-sectional study with data collected from 2041 
parturients who had undergone treatment between 2012 and 2014 in the maternity section 
of the Pedro Ernesto Hospital of the State University of Rio de Janeiro, in the metropolitan 
area of Rio de Janeiro. The inclusion criterion was positive VDRL and treponemal test in a 
hospital environment. Results: the prevalence of syphilis in pregnant women was 4.1% in 
2012, 3.1% in 2013 and 5% in 2014, with official reporting of 15.6%, 25.0% and 48.1%, 
respectively. The incidence of congenital syphilis (CS) was 22/1,000 in live births (LB) in 
2012; 17/1,000 LB in 2013 and 44.8/1,000 LB in 2014. CS underreporting during the period 
was 6.7%. Vertical transmission occurred in 65.8% of infants from infected mothers. It was 
concluded that, in 34.6% of the CS cases, maternal VDRL titers were = 1/4. Conclusion: 
Results demonstrate the magnitude of the disease, fragility of the reporting system in the 
assessment of the actual prevalence, impact on perinatal outcomes, and they are a warning 
about the real situation of syphilis, which is still underestimated in the State.
KEYWORDS: Syphilis. Gestation. Congenital syphilis. Prevalence. VDRL. Treponemal 
tests. Treponema pallidum.
INTRODUCTION
Syphilis is a sexually transmitted disease caused by the bacterium Treponema 
pallidum. Infection can be transmitted to the unborn child through the placenta 
at any gestational stage. In exceptional cases, syphilis can be transmitted at birth 
through the child’s contact with the birth canal, when there are maternal genital 
lesions (direct transmission). Syphilis may only be transmitted through breastfeeding 
if there are breast syphilis lesions1.
Congenital infection is associated with adverse outcomes, including: perinatal 
death, preterm birth, low birth weight, congenital anomalies, active syphilis in the 
newborn (NB), and long-term sequelae, such as deafness and neurological impairment2.
 There is a significant global increase in the prevalence of syphilis in pregnant 
women, despite all efforts from governments to control the disease. In 2013, the WHO 
reported 1.9 million pregnant women infected with syphilis worldwide, with 66.5% 
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of adverse fetal outcomes occurring in cases of untreated 
syphilis3. Congenital syphilis significantly contributes to 
infant mortality, accounting for 305,000 perinatal deaths 
per year worldwide4. There are more newborns affected 
by syphilis than by any other neonatal infection. It 
is estimated that 520,000 adverse fetal outcomes occur 
worldwide each year, making congenital syphilis more 
common than congenital HIV infection5. In areas where 
syphilis is prevalent, about half of the stillbirth rate 
may have been caused solely by this infection6. The 
direct medical cost associated with adverse fetal outcomes 
resulting from syphilis is U$ 309 million dollars a year4.
High rates of syphilis in parturients mean a high 
incidence of congenital syphilis and millions of missed 
opportunities to save lives during pre-natal care. Over 
the past ten years, the infant mortality rate due to syphilis 
increased 150% in Brazil, from 2.2 per 100,000 live births 
(LB) in 2004 to 5.5 per 100,000 LB in 2013. By 2015, 
the State of Rio de Janeiro had the highest rate of syphilis 
during pregnancy (2.2%) and of congenital syphilis in the 
country (16 cases per 1,000 LB)7,8.
The last syphilis monitoring study in pregnant women 
performed in Brazil in 2014, with a statistical sample from 
public and private hospitals, estimated the prevalence of 
syphilis at 1.02%, with no significant regional differences9.
According to the prediction curve of the disease, the 
Ministry of Health (MH) expected 40,000 cases in pregnant 
women in Brazil in 2016. An epidemic of the disease in the 
country was confirmed by the Ministry of Health in 2016. 
The increased incidence of syphilis in pregnant women is 
alarming8. In 2015, according to the MH, the States of Rio de 
Janeiro and Mato Grosso do Sul were the most affected in the 
country, reaching a syphilis rate in pregnant women of 2.2%8.
The national studies show differences in the prevalence 
of the disease according to the region studied, with rates 
ranging around 0.4% in Vitória (Espírito Santo)10, Itajaí 
(Santa Catarina)11 and 7.7% in Fortaleza (Ceará)12.
The analysis of international studies on the subject 
in countries such as Haiti13 shows that the prevalence of 
syphilis in pregnant women reaches 7.6%, while in other 
countries, such as Canada, syphilis has already been 
eliminated14. The WHO certified Cuba in 2013 as the first 
country to eliminate the vertical transmission of HIV and 
syphilis during pregnancy. Six other countries are currently 
able to request the WHO to validate the double elimination, 
including Canada and the United States15. 
Aim
To estimate the prevalence and coverage of syphilis 
reporting in parturients, the incidence of congenital syphilis 
and its corresponding underreporting, as well as the rate of 
vertical transmission of infection.
MATERIALS AND METHODS
Study design
Cross-sectional study. 
Studied population
A total of 2,041 pregnant women were recruited after 
admission to a public hospital in the metropolitan region 
of Rio de Janeiro, between January 2012 and December 
2014. The institution involved in the study was the Pedro 
Ernesto Hospital of the State University of Rio de Janeiro 
(HUPE / UERJ).
Data collection
At HUPE, blood samples are routinely collected for 
syphilis investigation upon admission, with both non-
treponemal testing (VDRL-Venereal Disease Research 
Laboratory) and confirmatory treponemal test (TPHA-
Treponema Pallidum Hemagglutination). The confirmation 
via the treponemal test is important due to the possibility 
of a false-positive result. All the tests were performed in 
the clinical analysis laboratory of HUPE. According to the 
protocol of the Brazilian Ministry of Health, blood samples 
are collected for syphilis testing from all parturients. An 
active search of syphilis serology results (treponemal 
and non-treponemal tests) with the respective titrations 
was conducted by accessing the database of the hospital 
laboratory. A thorough review of the medical records of 
pregnant women and their newborns was also conducted. 
Data from the HUPE epidemiology service were evaluated 
in order to identify the total number of infected pregnant 
women and newborns, in order to avoid underestimating the 
results. A survey was conducted on the website of the State’s 
Department of Health website to collect data on syphilis 
reports during pregnancy, as well as reports of congenital 
syphilis on the SINAN (National Disease Notification 
System) and the number of live births in the SINASC (Live 
Births Notification System).
Inclusion criterion
The following parturients were eligible for the study: 
pregnant women admitted for delivery with a live fetus of 
any gestational age and weight, stillbirths with gestational 
age equal to22 weeks or weight equal to 500 grams. 
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The following cases were defined as syphilis during 
pregnancy: all cases in which the parturient was admitted 
with laboratory evidence of positive VDRL (any titer) 
collected at the time of admission and confirmed by the 
treponemal test; all cases in which the parturient’s newborn 
(stillbirth or live birth) has been reported as a case of 
congenital syphilis (CS), identified in any of the information 
systems consulted.
Exclusion criterion
The following parturients were excluded: the ones with 
positive VDRL resulting from adequately treated previous 
syphilis (complete treatment with benzathine penicillin, 
according to the clinical stage of the disease, complete 
treatment of the partner, documentation confirming the couple’s 
treatment, drop in VDRL titers after adequate treatment, 
treatment completed more than 30 days before delivery).
Variable definition
The following situations were included as CS cases: all 
the gestation products (live births or stillborn) identified 
in any of the information systems as premature congenital 
syphilis; all newborns with VDRL titers higher than the 
maternal ones; all newborns with clinical manifestations 
suggestive of syphilis or complementary tests pointing to CS7.
Epidemiological definitions
According to the recommendation of the strategic 
management of the MH, the prevalence of syphilis in 
pregnant women is the ratio of the number of cases of 
syphilis detected in pregnant women to every 1,000 live 
births, within a geographical space and for a given period. 
For the purpose of calculating the prevalence, we used as 
the numerator the number of cases of syphilis detected in 
pregnant women, in a given notification year and place 
of residence multiplied by 1,000 and divided by the total 
number of live births in the same place and in the same 
reported year16. The numerator could be found in the SINAN 
(national disease notification system) and the denominator 
in the SINASC (live births information system).
For the calculation of the prevalence of parturients as a 
percentage, the number of cases of syphilis in parturients 
identified in the study was used as the numerator; the 
number of live births in that place and period, multiplied 
by 100 as the denominator.
To evaluate underreporting, we divided the number 
of parturients with syphilis in SINAN by the number of 
parturients with syphilis in hospitals x 100.
Following the MH recommendation for the calculation 
of the CS incidence, the number of CS cases identified in 
the study was used as the numerator and the number of live 
births at that location and period, multiplied by 1000, as 
the denominator.
In order to evaluate the underreporting of congenital 
syphilis, we divided the number of CS cases by the number 
of cases reported in SINAN x 100.
Data analysis
The sample size was calculated considering an expected 
prevalence of syphilis in pregnant women according to 
the MH in public hospitals of 1.1% in 2006, in Brazil9. 
To perform this calculation, assuming an error of 5% and 
a confidence interval (CI) of 95% the sample size was 
calculated to be 17 for 95% CI and 46 for 99,9% CI.
Collected variables were used in the comparative 
analyzes to identify prevalence factors. The results were 
expressed as percentages. The process of entering and 
analyzing statistical data was performed through the EPI-
INFO 3.5.2 version 3.0.1 computing program.
Considerations on ethical aspects
The research project was carried out within the standards 
required by the Declaration of Helsinki and Resolution 
466 of December 12, 2012, and approved by the Research 
Ethics Committee of the UERJ (COEP) in July 2012, 
process Nº 034.3.2012 and sponsored by FAPERJ, process 
Nº E-26/110.351/2012.
RESULTS
A total of 2,041 parturients were studied in HUPE: 735 
in 2012, 664 in 2013 and 642 in 2014. After the exclusion 
of 19 pregnant women due to serological scarring or 
false-positive results (treponemal negative test), 79 cases 
of parturients with syphilis were identified: 32 cases in 
2012, 20 in 2013 and 27 in 2014. Access to the result of 
the treponemal and non-treponemal tests for syphilis was 
obtained from all the pregnant women admitted during the 
period.
The search on SINASC, considering HUPE as the place 
of birth, totaled 1,956 live births in HUPE for the three years 
studied, with 773 live births in 2012, 647 in 2013 and 536 
in 2014. The prevalence of syphilis in the HUPE, using the 
number of live births officially described in SINASC as the 
denominator, was 4.1% in 2012, 3.1% in 2013 and 5.0% 
in 2014. Between 2012 and 2014, there was an increase on 
the prevalence of the disease (Table 1).
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The search on SINAN came up with 23 cases of syphilis 
in HUPE for the three years studied (2012 = 5, 2013 = 5 
and 2014 = 13). The research showed 79 cases in the three 
years (2012 = 32, 2013 = 20 and 2014 = 27).
Therefore, 15.6% of cases in 2012, 25.0% in 2013 and 
48.1% in 2014 were reported, which shows a significant 
increase for the period.
Three parturients (3.8%) from HUPE were double 
counted in the prevalence calculation, when they were 
admitted with syphilis at the time of delivery of subsequent 
pregnancies. One of the three parturients had VDRL titer 
=1/4 and progressed to 1/128 in the next gestation. The 
other two had 1/32 titers in the first gestation and had titers 
of 1/32 and 1/128, respectively, in subsequent pregnancies.
The incidence of CS was 22/1,000 LB in 2012, 17/1,000 
LB in 2013 and 44.8/ 1,000 LB in 2014. The notification 
of congenital syphilis reached 92.3% of the cases and only 
four cases were not officially reported. The present study 
demonstrated a vertical transmission rate of 65.8%, with 
52 newborns affected by congenital syphilis.
From the group of parturients with vertical transmission of 
the disease, 18 mothers had VDRL titers = 1/4, corresponding 
to 34.6% of the cases of congenital syphilis. The vertical 
transmission occurred in two consecutive pregnancies in one 
case that was within the low titers group (= 1/4). 
DISCUSSION
The latest national studies in public or public-private 
hospitals that monitor the prevalence of syphilis in the 
country demonstrated a reduction in the prevalence of 
syphilis among parturients in Brazil. Sentinel studies 
revealed a prevalence of 1.6%17 in 2004 and 1.02%9 in 2014.
However, the present study does not confirm this trend 
and demonstrates that the disease is not under control in 
the State of Rio de Janeiro. In 2014, the prevalence rate of 
5.0% was four-fold higher than the one registered in the 
country in 2014 by Domingues et al.19 and twice higher 
than the one registered in the State of Rio de Janeiro in 
2008 by the same author18.
The results are similar to those described by the MH 
regarding the ascending curve of the disease in recent years, 
but they express a significantly higher prevalence when 
compared with data from the epidemiological surveillance 
agencies for the same period. In 2014, although the State 
of Rio de Janeiro had the highest syphilis rate in pregnant 
women in the country (2.2%), the prevalence registered at 
HUPE was 2.3 times higher than the official one10.
The prevalence registered in 2012 was similar to the one 
of the Republic of Congo in Africa (4.2%)19. It was superior 
to levels in other Latin American countries in the three years 
studied and it is a warning regarding the epidemiological 
situation of syphilis in the State20. 
For some authors, the increase in the disease prevalence 
in the country may be associated with the improvement in 
the diagnosis and reporting systems, and not necessarily 
with the rise in the total number of cases. However, for some 
infectologists, the rising prevalence is due to the increasing 
practice of unprotected sex, which would intensify the 
number of cases of syphilis in the adult population and, 
consequently, during pregnancy. For others, there are flaws 
in the gestation treatment of prenatal services, in both 
diagnosis and treatment of the pregnant women and their 
partners7,21.
A possible limitation of the present study is the 
selection bias, since the prevalence can be overestimated 
by including parturients with serological scarring (<1/8) in 
their calculation, even after the meticulous evaluation of the 
medical records and considering epidemiological history. 
The MH considers low VDRL titers when diagnosing 
syphilis, due to the variations in readings and the lack of 
detection by the tests. All the national studies consulted, 
including the sentinel studies in parturients, used any 
VDRL title for the calculation of the prevalence in its 
methodology9,22. Furthermore, several authors have already 
described the clinical significance of low titers of VDRL in 
the diagnosis of congenital syphilis23.
Although there has been a substantial increase in the 
reporting of syphilis in parturients in HUPE between 
2012 and 2014, it has not reached half of the cases, which 
Table 1 - Prevalence of syphilis in parturients between 2012 and 2014 at HUPE, Rio de Janeiro, Brazil
Year Frequency LB SINASC % (CL 95%) Prevalence 
(cases/1.000 LB) 
Prevalence
(%)
2012 32 773 4.1 (2.9-5.8) 41.4 4.1
2013 20 647 3.1 (1.9-4.7) 31.0 3.1
2014 27 536 5.0 (3.4-7.2) 50.4 5.0
Total 79 1956 4.0 (3.2-5.0) 40.3 4.0
Legend: live births (LB); live birth information system (SINASC); confidence limit (CL)
Source: the authors, 2017
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demonstrates how fragile the epidemiological surveillance 
system is in identifying and reporting all cases. The 
considerable increase in the coverage of notifications follows 
the increased number of notifications observed in Brazil, 
which, according to the MH, is related to the Rede Cegonha 
program, which increased the coverage of pregnant women 
testing and follow-up of cases24. In Brazil, between 2012 and 
2013, there was a 25% increase in the number of syphilis 
reports in pregnant women, and 23% if only the Southeast 
region is considered, which is responsible for 45.9% of 
the country’s notifications. The increase of the number of 
notifications in the State of Rio de Janeiro was 16%. In the 
country, São Paulo is the State with the highest number of 
notifications, followed by the State of Rio de Janeiro25.
Although the surveillance agencies considered 
underreporting for the purposes of disease monitoring, the 
present study shows that the level of underreporting was 
higher than estimated and should not be used as a basis 
for calculation. Without the proper notification, there is 
a tendency to underestimate the problem. However, the 
underreporting found in HUPE in 2013 is similar to the one 
described by Cavalcante et al.26 in Fortaleza and Domingues 
et al.18 in SUS units (state health clinics and hospitals) in 
the city of Rio de Janeiro, where underreporting was 73%, 
70.3% and 76.1%, respectively, demonstrating the fragility 
of the information services in Brazil to work as a basis for 
promoting measures to combat the disease.
The high prevalence of the disease among the parturients 
of the present study resulted in an incidence of congenital 
syphilis (26.6 per 1,000 LB) greater than that reported in 
the State of Rio de Janeiro in 2015 (16 per 1,000 LB)10 and 
at least five-fold greater than the incidence of the disease in 
Brazil, according to the Nascer Study (3.51 per 1,000 LB)27.
Regarding the notification of congenital syphilis, the 
present study reached more than 90%, a result far superior 
to that reported by the MH, which estimates notification 
at only 17.4% of the cases of CS in the country24. HUPE 
is located in the capital of the State of Rio de Janeiro and, 
according to the epidemiological bulletin of the State 
Health Department, it is the city with the highest number 
of notifications of CS in the State (63.5%)25.
The high vertical transmission rate of syphilis in this 
study (65.8%) shows the high prevalence of syphilis among 
parturients, since among the various diseases that can be 
transmitted during the puerperal-pregnancy cycle, syphilis 
is the one that presents the greater chances of transmission28. 
Kupek et al.11 showed similar rates (68.9%). Domingues 
et al.18 and the MH7, however, estimated lower rates of 
vertical transmission, 34.8% in Rio de Janeiro and 25% in 
Brazil, respectively.
The occurrence of maternal syphilis in a subsequent 
gestation demonstrated that a prior gestation with 
syphilis did not eliminate the risk of the disease in future 
pregnancies. The recurrence of syphilis in two distinct 
pregnancies is the major sign of the inefficiency of the health 
system in properly conducting these cases.
Fetal infection occurred even in the presence of low 
VDRL maternal titers. The lack of proper consideration 
of low titers of VDRL by the health professionals is still 
a barrier to the control of congenital syphilis. In a study 
with health professionals, it was observed that only 48% 
had adequate knowledge about the management of syphilis, 
especially regarding the treatment of pregnant women with 
low titration29.
Since syphilis is an easily diagnosed disease that has an 
established treatment and generates low costs for testing and 
treatment during pregnancy, it should be possible to control 
the disease. However, the disease continues to advance in 
Brazil in alarming numbers.
CONCLUSIONS
The estimated prevalence of syphilis in pregnant 
women in Rio de Janeiro is at least twice as high as 
previously reported by regional studies and epidemiological 
surveillance data in the State, reaching levels found in 
African countries and higher than the figures for other 
countries in Latin America. These values are a warning on 
the magnitude of the disease in the State of Rio de Janeiro, 
its upward curve and its consequences. Our reporting 
system has proven to be fragile and unable to assess the 
current prevalence of syphilis in Rio de Janeiro, which 
is underestimated. Due to the high prevalence of syphilis 
among parturients, there was a high rate of CS and vertical 
transmission that occurred even in pregnant women with 
low VDRL titers, emphasizing the importance of evaluating 
low titers in the management of these patients.
It is a responsibility of the health professionals, who 
daily handle this sad reality, to strive for excellence in caring 
for pregnant women. Even in the 21st century, the high rates 
of syphilis in parturients and CS in Brazil are still ignored 
and underestimated.
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